Rising Demand for Erythropoietin Drugs Drives Growth in Global Anemia Treatment Market

Erythropoietin drugs are medications that stimulate the production of red blood cells in the body. Red blood cells are responsible for carrying oxygen to the body's tissues, so when there aren't enough red blood cells, a person can become anemic, which can cause fatigue, shortness of breath, and other symptoms.

The global erythropoietin drugs market size was valued at $9,243.12 million in 2020, and is projected to reach $14,414.59 million by 2028, registering a CAGR of 5.7% from 2021 to 2028.

𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐚𝐭:

https://www.alliedmarketresearch.com/request-sample/59

Erythropoietin is a hormone that is naturally produced by the kidneys and stimulates the production of red blood cells in the bone marrow. Erythropoietin drugs work by mimicking this hormone and stimulating the bone marrow to produce more red blood cells.

Erythropoietin drugs are often used to treat anemia in people with chronic kidney disease or cancer. They may also be used in people who are scheduled for certain surgeries to reduce the need for blood transfusions. These drugs are usually given as injections, either under the skin or directly into a vein.

Covid-19 scenario:

The outbreak of Covid-19 disrupted the workflow in the healthcare sector as the rapid spread of coronavirus forced several industries to shutdown temporarily.

However, the pandemic had a positive effect on the demand for medical services including erythropoietin.

As erythropoietin is used to treat anemia and can be effective against Covid-19, which boosted its demand. Moreover, it has anti-ischemic, anti-apoptotic, and regenerative effects in several tissues such as kidney, lungs, nervous system, retina, and pancreas. Thus, it can be used to treat critically ill patients.

𝐀𝐬𝐤 𝐭𝐨 𝐎𝐮𝐫 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐄𝐱𝐩𝐞𝐫𝐭:
https://www.alliedmarketresearch.com/purchase-enquiry/59

Erythropoietin drugs are used in medical treatments that aim to stimulate the production of red blood cells in the body. These drugs are primarily used to treat conditions that result in anemia, which is a condition in which there are not enough red blood cells in the body.

Some of the medical conditions that may be treated with erythropoietin drugs include:

Chronic kidney disease: Erythropoietin drugs are often prescribed to people with chronic kidney disease who experience anemia as a result of their condition.

Cancer: Some types of cancer can cause anemia, and erythropoietin drugs may be prescribed to cancer patients to stimulate the production of red blood cells.

HIV: Erythropoietin drugs may be prescribed to people with HIV who experience anemia as a side effect of their medication.

Surgical procedures: Erythropoietin drugs may be used in patients who are scheduled for certain surgeries to reduce the need for blood transfusions.

It's important to note that the use of erythropoietin drugs should always be under the supervision of a medical professional, as there may be potential risks and side effects associated with their use.

The global erythropoietin drugs market is analyzed across several regions such as North America, Europe, Asia-Pacific, and LAMEA. The market across North America held the largest share in 2020, accounting for more than one-third of the market. However, the market across Asia-Pacific is projected to register the highest CAGR of 7.8% from 2021 to 2028.

𝐋𝐞𝐚𝐝𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭 𝐏𝐥𝐚𝐲𝐞𝐫𝐬:-

The global erythropoietin drugs market includes an in-depth analysis of the prime market players such as Johnson & Johnson, Amgen Inc., Roche, Hospira Inc., Biocon, LG Life Sciences Ltd., Teva Pharmaceutical Industries Ltd., Intas Pharmaceuticals, Ranbaxy Laboratories Ltd., and Celltrion, Inc.

𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐢𝐧 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲:

Synthetic Biology Market: https://www.alliedmarketresearch.com/synthetic-biology-market

Intravenous Immunoglobulin Market:
https://www.alliedmarketresearch.com/intravenous-immunoglobulin-ivig-market

Liver Disease Treatment Market: https://www.alliedmarketresearch.com/liver-diseases-therapeutics-market

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

This release was published on openPR.